A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

Mª AUXILIADORA GÓMEZ ESPAÑA2026-01-292026-01-29202310.1016/j.biopha.2023.1142722-s2.0-85147418714https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36018PharmacologyA signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patientsresearch article